Watchlist Price Alert

NeuroSense Therapeutics L... (NRSNW)

NASDAQ: NRSNW · Real-Time Price · USD

0.82

-0.03 (-3.53%)

At close: Jun 18, 2025, 10:40 AM

NeuroSense Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-10.21M	-10.11M	-12.34M	-4.04M	-2.83M	-1.22M
Depreciation & Amortization	22K	21K	89K	3K	3K	n/a
Stock-Based Compensation	557K	1.54M	5.11M	4.16M	2.06M	611K
Other Working Capital	-482K	928K	291K	289K	37K	6K
Other Non-Cash Items	277K	-1.71M	-1.19M	791K	-2K	591K
Deferred Income Tax	n/a	n/a	n/a	-2.72M	2K	n/a
Change in Working Capital	-781K	1.91M	750K	273K	69K	29K
Operating Cash Flow	-10.13M	-8.35M	-7.59M	-1.54M	-695K	-582K
Capital Expenditures	-3K	-29K	-70K	-17K	-9K	-7K
Cash Acquisitions	n/a	3K	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	-3.5M	n/a	n/a	-19K
Sales Maturities Of Investments	n/a	3.5M	n/a	n/a	n/a	n/a
Other Investing Acitivies	4K	-6K	29K	n/a	n/a	-19K
Investing Cash Flow	1K	3.47M	-3.54M	-17K	-9K	-26K
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-391K	n/a	3.69M	2.04M	n/a	-3K
Financial Cash Flow	10.91M	3.98M	3.69M	11.9M	508K	1.42M
Net Cash Flow	738K	-903K	-7.52M	10.36M	-196K	809K
Free Cash Flow	-10.14M	-8.38M	-7.66M	-1.56M	-704K	-589K